Sarah Jessica Parker has cut ties with Mylan, the company that makes EpiPen, after it was criticised for raising the price of the life-saving allergy product by 400 per cent. Parker announced her decision last night on Instagram.
Tagged With sarah jessica parker
EpiPen, the life-saving allergy product, is now a $US1 billion ($1.3 billion) a year business for Mylan, a drug company that's currently enduring a wave of bad publicity over the extraordinary surge in US EpiPen pricing. In 2007, an EpiPen in the US cost about $US57 ($75). Today that price has skyrocketed to over $US600 ($787) -- all for about $1 worth of injectable medicine.